Skip to main content
. 2000 Nov 28;97(25):13714–13719. doi: 10.1073/pnas.240335297

Table 1.

AAV minidystrophin gene transfer in young and adult mdx mice

Animals* and vectors n Age at vector injection Months post injection % Dystrophin-positive fibers % Central nuclei
mdx + Δ3849 4 10 days 3 56 ∼ 88 1.02 (72/7,098)
mdx + Δ3990 4 10 days 3 50 ∼ 80 0.99 (56/5,652)
mdx + Δ4173 4 10 days 3 15 ∼ 25 0.93 (26/2,791)
mdx + Δ3849 4 10 days 6 40 ∼ 60 2.80 (51/1,824)
mdx + Δ3990 2 10 days 6 35 ∼ 45 2.30 (34/1,478)
mdx + Δ3849 2 50 days 2 35 ∼ 50 34.76 (510/1,467)
mdx + Δ3990 2 50 days 2 35 ∼ 40 34.18 (685/2,004)
mdx + Δ3849 4 50 days 4 20 ∼ 25 44.24 (615/1,390)
mdx + Δ3990 4 50 days 4 20 ∼ 30 46.18 (695/1,505)
C57/B10 4 No injection N/A 100 1.45 (56/3,860)
mdx 4 No injection N/A <1 75.4 (238/3,160)

N/A, Not applicable. 

*

Untreated control mdx and C57/B10 mice were about 3 months old at the endpoints of experiments. AAV vectors were driven by MCK promoter. 

All numbers were collected from dystrophin-positive myofibers that were photographed after IF staining and DAPI counterstaining, except in untreated mdx mice, which had extensive central nucleation and very few dystrophin-positive revertant myofibers.